Rubella Vaccine Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Funding
• Alerts
• Clinical Trials
• Forums

Immunogenicity & Safety of Bio Farma's Measles-Rubella (MR) Vaccine in Indonesian Infants (Bridging Study)
Conditions:   Congenital Rubella Infection;   Measles Interventions:   Biological: Measles-Rubella vaccine Bio Farma;   Biological: MR Vaccine SII Sponsor:   PT Bio Farma Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 3, 2019 Category: Research Source Type: clinical trials

Clinical Trial for Measles - Rubella Combined Vaccine (MRVAC) Produced by POLYVAC (Phase III)
Condition:   Signs and Symptoms Interventions:   Biological: Trial arm (MRVAC);   Biological: Control arm Sponsors:   Center for Research and Production of Vaccines and Biologicals, Vietnam;   Vietnam Military Medical University Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 19, 2018 Category: Research Source Type: clinical trials